Correction: TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2. 2. 15 cells by activating the JAK–STAT signaling pathway
X. Zhu, C. Xie, Y. -M Li, Z. -L Huang, Q. -Y Zhao, Z. -X Hu, P. -P Wang, Y. -R Gu, Z. -L Gao, L. Peng
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHepatitis B Virus Studies · Liver Disease Diagnosis and Treatment
Correction to: Cell Death & Disease 10.1038/cddis.2016.146, published online 2 June 2016
Due to an oversight in figure selection, the original representative image of Figure 7C (HBcAg Control, HBcAg TMEM2+JAKI) is incorrect. However, this does not affect the experimental conclusions. Therefore, it is necessary to correct Figure 7C (HBcAg Control, HBcAg TMEM2+JAKI).